Novel Targets for Drugs in Schizophrenia

E-ISSN： 1996-3181|6|4|265-272

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.6, Iss.4, 2007-08, pp. : 265-272

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Modeling schizophrenia: uncovering novel therapeutic targets

By Desbonnet Lieve O'Tuathaigh Colm MP Waddington John L

Expert Review of Clinical Pharmacology, Vol. 5, Iss. 6, 2012-11 ,pp. : 667-676

Informa Healthcare

Access to resources Recommend Favorite

Treating Schizophrenia: Novel Targets for the Cholinergic System

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 9, Iss. 2, 2010-04 ,pp. : 241-256

Bentham Science Publishers

Access to resources Recommend Favorite

PDE10A Inhibitors: Novel Therapeutic Drugs for Schizophrenia

Current Pharmaceutical Design, Vol. 17, Iss. 2, 2011-01 ,pp. : 137-150

Bentham Science Publishers

Access to resources Recommend Favorite

Serotonin Receptors as Targets for Drugs Useful to Treat Psychosis and Cognitive Impairment in Schizophrenia

Current Pharmaceutical Biotechnology, Vol. 13, Iss. 8, 2012-06 ,pp. : 1572-1586

Bentham Science Publishers

Access to resources Recommend Favorite

Histone modification enzymes: novel targets for cancer drugs

By Kristeleit Rebecca Stimson Lindsay Workman Paul Aherne Wynne

Expert Opinion on Emerging Drugs, Vol. 9, Iss. 1, 2004-05 ,pp. : 135-154

Informa Healthcare

Access to resources Recommend Favorite